Association between an R338L mutation in the thyroid hormone receptor- β gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone

Thyroid

Volumn 9, Issue 1, 1999, Pages 1-6

  Menzaghi, Claudia ^a   Balsamo, Armando ^b   Di Paola, Rosa ^a   Gallone, Gabriella ^b   Rossi, Claudio ^b   Tassi, Vittorio ^a   Fonzo, Domenico ^b   De Filippis, Vito ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE RECEPTOR;

ARTICLE; CASE REPORT; GENE MUTATION; HEART PALPITATION; HEAT SENSITIVITY; HUMAN; PRIORITY JOURNAL; THYROID HORMONE RELEASE; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; TREMOR;

EID: 0032999077     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.1     Document Type: Article

References (24)

1. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
2. Lazar MA 1993 Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 14:184-193.
3. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, McBride OW, Weintraub BD 1988 Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbAβ gene. Mol Endocrinol 2:1217-1220.
4. Hayashi Y, Weiss RE, Same DH, Yen PM, Sunthorthepvarakul T, Marcocci C, Chin WW, Refetoff S 1995 Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone β-receptors? J Clin Endocrinol Metab 80:3246-3256.
5. Yen PM, Chin WW 1994 Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol Endocrinol 8:1450-1454.
6. Collingwood TN, Adams M, Tone Y, Chatterjee VKK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277.
7. Jameson JL 1994 Mechanism by thyroid hormone receptors mutations cause clinical syndromes of resistance to thyroid hormones. Thyroid 4:485-492.
8. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, Weintraub BD 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. Ann Intern Med 123:572-583.
9. Beck-Peccoz P, Chatterjee VKK 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232.
10. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee VKK 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. J Clin Invest 94:506-515.
11. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, Tollin S, Hegarty MK, Wondisford FE 1994 A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem 269: 32713-32716.
12. Chatterjee VKK 1996 Aetiology and pathogenesis of thyroid hormone resistance. Topical Endocrinol 4:2-5.
13. Safer JD, Langlois MF, Cohen R, Monden T, John-Hope D, Madura J, Hollenberg AN, Wondisford FE 1997 Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol Endocrinol 11:16-26.
14. Brunn J, Block U, Ruf G, Bos J, Kunze WP, Scriba PC 1981 Volumetrie der schilddrusenlappen mittels real-time-sonographie. Dtsch Med Wochenschr 106:1338-1340.
15. Panella C, Guglielmi FW, Marcone I, Barone M, Amoruso A, Francavilla A 1991 Standard antropometrici di riferimento nazionali: studio sulla popolazione pugliese. Riv Ital Nutriz Parent Enter 9:41-48.
16. Ainsworth PJ, Surth LC, Coulter-Mackie MB 1991 Diagnostic single strand conformational polymorphism (SSCP): A simplified non-radioisotopic method as applied to a Tay-Sachs B1 variant. Nucleic Acids Res 19:405-406.
17. Ganly PS, Jarad N, Rudd RM, Rabbits PH 1992 PCR-based RFLP analysis allows genotyping of the short arms of chromosome 3 in small biopsies from patients with lung cancer. Genomics 12:221-228.
18. De Filippis V, Gallone G, Patrito G, Zoppetti G, Zingrillo M 1990 Inappropriate secretion of TSH (IST). Coexistence in patients with non tumoral IST of peripheral resistance variable in degree among individuals and tissues. J Endocrinol Invest 13(suppl 1):181.
19. Kojima N, Sakata S, Nakamura S, Nagai K, Takuno H, Ogawa T, Matsui I, Sarui H, Miura K 1992 Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis. J Endocrinol Invest 15:491-496.
20. Calvo MS, Eyre DR, Gundberg CM 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333-368.
21. Watanabe K, Kameya T, Iyamauchi A, Yamamoto N, Kuwayama A, Takei I, Maruyama H, Saruta T 1993 Thyrotropin-producing adenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 76:1025-1030.
22. Ando S, Nakamura H, Sasaki S, Nishiyama K, Kitahara A, Nagasawa S, Mikami T, Natsume H, Genma R, Yoshimi T 1996 Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities. J Endocrinol 151:293-300.
23. Kitajima K, Nagaya T, Jameson JL 1995 Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Thyroid 5:343-353.
24. Ng L, Forrest D, Haugen BR, Wood WM, Curran T 1995 N-terminal variants of thyroid hormone receptor β: Differential function and potential contribution to syndrome of resistance to thyroid hormone. Mol Endocrinol 9:1202-1213.